Viking Therapeutics
World Rank (Aug-2026)
4,274
Market Cap (Aug-2026)
3.872 Billion USD
World Rank (Jan-05-2024)
5,954
Market Cap (Jan-05-2024)
1.859 Billion USD
World Rank (Jul-30-2023)
7,050
Market Cap (Jul-30-2023)
1.442 Billion USD
World Rank (Dec-25-2022)
10,811
Market Cap (Dec-25-2022)
0.648 Billion USD
World Rank (Jan-07-2022)
16,059
Market Cap (Jan-07-2022)
0.33 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-360 Million USD
Annual Results for Period Ending
For year ending December-2025
Company Profile
Viking Therapeutics is a Clinical Stage Biopharmaceutical company. It is focused on the development of novel, orally available, first in class or best in class therapies for the treatment of metabolic and endocrine disorders. The company annual revenue is 7.3 million USD and 15 employees as 2019. The headquarters is in USA.
Company Website